MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Quinine sulfate 300mg tablets (Accord Healthcare Ltd).

Stability Notes

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Quinine sulfate 200mg tablets (Accord Healthcare Ltd).

Stability Notes

Protect from light and store in airtight containers.

Provenance

Compatibility recommendation derived from Paracetamol 500mg caplets and 500mg tablets (Zentiva Pharma UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 50mg tablets (Advanz Pharma).

Stability Notes

Protect from light and moisture. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Trimethoprim 100mg tablets (Crescent Pharma Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Zydol 50mg capsules (Grunenthal Ltd) and Tramadol 50mg capsules (Milpharm Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 1microgram capsules (Neon Healthcare Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 250nanogram capsules (Neon Healthcare Ltd) and Alfacalcidol 250nanogram capsules (Strides Pharma UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 500nanogram capsules (Neon Healthcare Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.